by Jesmond Dalli, and Charles N. Serhan

Slides:



Advertisements
Similar presentations
Glioma-derived soluble factor(s) enhance IL-10 signaling.
Advertisements

Introduction Various pro-inflammatory markers (e.g., IL-6, TNF, prostaglandins) robustly respond to acute sleep deficiency, whether measured in urine,
Involvement of suppressors of cytokine signaling in toll-like receptor–mediated block of dendritic cell differentiation by Holger Bartz, Nicole M. Avalos,
IFNα-stimulated neutrophils and monocytes release a soluble form of TNF-related apoptosis-inducing ligand (TRAIL/Apo-2 ligand) displaying apoptotic activity.
Identification of key regulatory pathways of myeloid differentiation using an mESC-based karyotypically normal cell model by Dong Li, Hong Yang, Hong Nan,
by Jacob Rachmilewitz, Gregory J
by Adam M. Zawada, Kyrill S
Dendritic cell differentiation potential of mouse monocytes: monocytes represent immediate precursors of CD8- and CD8+ splenic dendritic cells by Beatriz.
by Masih Ostad, Margareta Andersson, Astrid Gruber, and Anne Sundblad
CD56+/CD16− Natural Killer cells expressing the inflammatory protease granzyme A are enriched in synovial fluid from patients with osteoarthritis  P.
Homogeneous monocytes and macrophages from human embryonic stem cells following coculture-free differentiation in M-CSF and IL-3  Karl R. Karlsson, Sally.
Albumin Counteracts Immune-Suppressive Effects of Lipid Mediators in Patients With Advanced Liver Disease  Louise China, Alexander Maini, Simon S. Skene,
by Kesheng Dai, Richard Bodnar, Michael C. Berndt, and Xiaoping Du
The CXC-chemokine platelet factor 4 promotes monocyte survival and induces monocyte differentiation into macrophages by Barbara Scheuerer, Martin Ernst,
A functional folate receptor is induced during macrophage activation and can be used to target drugs to activated macrophages by Wei Xia, Andrew R. Hilgenbrink,
Caspases Mediate Tumor Necrosis Factor-–Induced Neutrophil Apoptosis and Downregulation of Reactive Oxygen Production by Kouhei Yamashita, Atsushi Takahashi,
by Silke Huber, Reinhard Hoffmann, Femke Muskens, and David Voehringer
Circulating blood dendritic cells from myeloid leukemia patients display quantitative and cytogenetic abnormalities as well as functional impairment by.
Matthew Spite, Joan Clària, Charles N. Serhan  Cell Metabolism 
Metalloproteinases Are Involved in Lipopolysaccharide– and Tumor Necrosis Factor-–Mediated Regulation of CXCR1 and CXCR2 Chemokine Receptor Expression.
Ex vivo induction of multiple myeloma–specific cytotoxic T lymphocytes
Macrophages from C3-deficient mice have impaired potency to stimulate alloreactive T cells by Wuding Zhou, Hetal Patel, Ke Li, Qi Peng, Marie-Bernadette.
Sphingosylphosphorylcholine is a Potent Inducer of Intercellular Adhesion Molecule-1 Expression in Human Keratinocytes  Genji Imokawa, Yutaka Takagi,
Serum amyloid A is an innate immune opsonin for Gram-negative bacteria
Differentiation, phenotype, and function of interleukin-17–producing human Vγ9Vδ2 T cells by Nadia Caccamo, Carmela La Mendola, Valentina Orlando, Serena.
Expansion of FOXP3high regulatory T cells by human dendritic cells (DCs) in vitro and after injection of cytokine-matured DCs in myeloma patients by Devi.
Increased survival is a selective feature of human circulating antigen-induced plasma cells synthesizing high-affinity antibodies by Inés González-García,
The heat shock protein Gp96 binds to human neutrophils and monocytes and stimulates effector functions by Markus P. Radsak, Norbert Hilf, Harpreet Singh-Jasuja,
Volume 21, Issue 13, Pages (December 2017)
Functional human regulatory T cells fail to control autoimmune inflammation due to PKB/c-akt hyperactivation in effector cells by Ellen J. Wehrens, Gerdien.
The transcriptional program of terminal granulocytic differentiation
Nat. Rev. Rheumatol. doi: /nrrheum
Christopher D. Buckley, Derek W. Gilroy, Charles N. Serhan  Immunity 
Volume 4, Issue 6, Pages (June 1996)
Interaction of kindlin-3 and β2-integrins differentially regulates neutrophil recruitment and NET release in mice by Zhen Xu, Jiayi Cai, Juan Gao, Gilbert.
Volume 20, Issue 2, Pages (February 2013)
CD56+/CD16− Natural Killer cells expressing the inflammatory protease granzyme A are enriched in synovial fluid from patients with osteoarthritis  P.
by Eleanor J. Molloy, Amanda J. O'Neill, Julie J
by Ulrike Schleicher, Andrea Hesse, and Christian Bogdan
Volume 115, Issue 1, Pages (July 1998)
Surfactant protein D inhibits TNF-α production by macrophages and dendritic cells in mice  László Hortobágyi, MS, Sonja Kierstein, PhD, Kateryna Krytska,
Volume 141, Issue 3, Pages (September 2011)
Down-regulation of L-selectin expression in neutrophils by nonsteroidal anti-inflammatory drugs: role of intracellular ATP concentration by Maria Victoria.
Exosomes from human macrophages and dendritic cells contain enzymes for leukotriene biosynthesis and promote granulocyte migration  Julia Esser, BS, Ulf.
A Reducing Microenvironment Leads to the Generation of FcεRIhigh Inflammatory Dendritic Epidermal Cells (IDEC)  Natalija Novak, MD, Stefan Kraft, Jörg.
Soluble PD-1 ligands regulate T-cell function in Waldenstrom macroglobulinemia by Shahrzad Jalali, Tammy Price-Troska, Jonas Paludo, Jose Villasboas, Hyo-Jin.
Thiazolidinediones Regulate Adipose Lineage Dynamics
Volume 13, Issue 11, Pages (November 2006)
Kathleen R. Bartemes, BA, Gail M. Kephart, BS, Stephanie J
Dysregulated synthesis of protectin D1 in eosinophils from patients with severe asthma  Jun Miyata, MD, Koichi Fukunaga, MD, PhD, Ryo Iwamoto, MS, Yosuke.
Katherine G. MacDonald, BSc, Nicholas A. J
Human MSC Suppression Correlates With Cytokine Induction of Indoleamine 2,3- Dioxygenase and Bystander M2 Macrophage Differentiation  Moïra François, Raphaëlle.
Neutrophils in antiretroviral therapy–controlled HIV demonstrate hyperactivation associated with a specific IL-17/IL-22 environment  Laure Campillo-Gimenez,
by Silvia Mele, Stephen Devereux, Andrea G
Poly(I:C)-Treated Human Langerhans Cells Promote the Differentiation of CD4+ T Cells Producing IFN-γ and IL-10  Laetitia Furio, Hermine Billard, Jenny.
Cell-derived vesicles exposing coagulant tissue factor in saliva
Volume 39, Issue 5, Pages (November 2013)
Volume 22, Issue 3, Pages (March 2005)
Defective negative regulation of Toll-like receptor signaling leads to excessive TNF-α in myeloproliferative neoplasm by Hew Yeng Lai, Stefan A. Brooks,
Vagal Regulation of Group 3 Innate Lymphoid Cells and the Immunoresolvent PCTR1 Controls Infection Resolution  Jesmond Dalli, Romain A. Colas, Hildur.
Human CD4+ T Lymphocytes with Remarkable Regulatory Functions on Dendritic Cells and Nickel-Specific Th1 Immune Responses  Andrea Cavani, Francesca Nasorri,
by Defne Bayik, Debra Tross, Lydia A
Serotonin Activates Human Monocytes and Prevents Apoptosis
Volume 21, Issue 10, Pages (October 2014)
Filgrastim enhances T-cell clearance by antithymocyte globulin exposure after unrelated cord blood transplantation by Coco de Koning, Julie-Anne Gabelich,
Figure 2 Fingolimod impairs induction of activation markers on human monocytes Peripheral blood mononuclear cells from healthy donors were briefly exposed.
Volume 6, Issue 4, Pages (October 2009)
Targeting CD47 in Sézary syndrome with SIRPαFc
by Ganesh V. Halade, Paul C. Norris, Vasundhara Kain, Charles N
Evidence for a cross-talk between human neutrophils and Th17 cells
Presentation transcript:

by Jesmond Dalli, and Charles N. Serhan Specific lipid mediator signatures of human phagocytes: microparticles stimulate macrophage efferocytosis and pro-resolving mediators by Jesmond Dalli, and Charles N. Serhan Blood Volume 120(15):e60-e72 October 11, 2012 ©2012 by American Society of Hematology

PMN MPs enhance macrophage efferocytosis of apoptotic PMN PMN MPs enhance macrophage efferocytosis of apoptotic PMN. PMN MPs were obtained after PMN stimulation with formyl-methionyl-leucyl-phenylalanine (1μM). PMN MPs enhance macrophage efferocytosis of apoptotic PMN. PMN MPs were obtained after PMN stimulation with formyl-methionyl-leucyl-phenylalanine (1μM). (A) The MP population (left panel) was monitored by flow cytometry using fluorescently conjugated AnxAV (right top panel) and anti-CD66b (right bottom panel). (B) Macrophages were prepared by differentiating peripheral blood monocytes in the presence of GM-CSF for 7 days. These were incubated with MP for 5 minutes before the addition of apoptotic (Apo) PMN. Uptake of the CFDA-labeled Apo PMN (3 × 105 cells/well) was monitored after 1-hour incubation (37°C) by assessing the levels of fluorescence (see “Phagocytosis”). (B) Results are expressed as mean ± SEM (n = 4 distinct cell preparations). *P < .05 vs macrophage plus PMN group. **P < .01 vs macrophage plus Apo PMN group. Jesmond Dalli, and Charles N. Serhan Blood 2012;120:e60-e72 ©2012 by American Society of Hematology

SPM biosynthesis during macrophage efferocytosis of apoptotic PMNs is enhanced by PMN MPs. Macrophages were incubated for 5 minutes with PMN MPs before the addition of apoptotic PMNs (7.5 × 105 cells/well). SPM biosynthesis during macrophage efferocytosis of apoptotic PMNs is enhanced by PMN MPs. Macrophages were incubated for 5 minutes with PMN MPs before the addition of apoptotic PMNs (7.5 × 105 cells/well). Cells were incubated for 1 hour at 37°C. At the end of the incubation, ice-cold MeOH was added and the products extracted. (A) Representative MRM traces for the identified LMs. (B) Accompanying MS/MS spectra used for identification. (C) Specific bioactive lipid mediator and precursor/pathway markers where: Q1, M-H (parent ion); and Q3, diagnostic ion in the MS-MS (daughter ion) along with mean ± SEM values for each of the mediators identified. Quantification and values obtained after PMN (3 × 105 PMN) and MP (2 × 105 MP) incubations. The detection limit was ∼ 1 pg. *Below limits. (D) D-series resolvins, protectins, and maresins. (E) Lipoxins. (F) Prostaglandins and thromboxanes. (C-F) Results are expressed as mean ± SEM; n = 4 distinct cell preparations. *P < .05 vs macrophage group. **P < .01 vs macrophage group. #P < .05 vs macrophage plus Apo PMN group. Jesmond Dalli, and Charles N. Serhan Blood 2012;120:e60-e72 ©2012 by American Society of Hematology

Elevated SPM biosynthesis in apoptotic PMNs Elevated SPM biosynthesis in apoptotic PMNs. PMNs were isolated from peripheral blood of healthy volunteers and placed directly in MeOH (PMN), induced to apoptose (Apo PMN), or stimulated with zymosan (PMN + Zy). Elevated SPM biosynthesis in apoptotic PMNs. PMNs were isolated from peripheral blood of healthy volunteers and placed directly in MeOH (PMN), induced to apoptose (Apo PMN), or stimulated with zymosan (PMN + Zy). After extraction, LM profiles were obtained using LC-MS/MS (see “Sample extraction and lipid mediator metabololipidomics”). (A) Representative MRM chromatograms of the LM identified in the apoptotic or Zy-activated neutrophils. Peak heights represent the relative levels of each LM. Cumulative levels for individual LM families are depicted as a function of color intensity, where color scales (eg, white to blue [Apo PMN = ] or white to tan [Zy PMN = ]) are set from zero to 500 pg per 5 × 106 cells. (B) Accompanying MS/MS spectra used for identification. (C) Lipid mediator and precursor/pathway marker transition where: Q1, M-H (parent ion); and Q3, diagnostic ion in the MS-MS (daughter ion), along with mean ± SEM values for each of the mediators identified. Values are for 5 × 106 PMNs. The detection limit was ∼ 1 pg. *Below limits. Cumulative values: (D) Leukotriene B4 (and 20-OH LTB4 metabolite). (E) D-series resolvins, protectins, and maresins. (F) Lipoxins. (G) E-series resolvins and lipoxins. (H) Prostaglandins and thromboxanes. (C-H) Results are expressed as mean ± SEM; n = 5 distinct cell preparations. *P < .05 vs PMNs. **P < .01 vs PMNs. ***P < .01 vs PMNs. #P < .05 vs Apo PMNs. Jesmond Dalli, and Charles N. Serhan Blood 2012;120:e60-e72 ©2012 by American Society of Hematology

Macrophage phagocytosis of apoptotic PMNs Macrophage phagocytosis of apoptotic PMNs. A nidus for transcellular biosynthesis. Macrophage phagocytosis of apoptotic PMNs. A nidus for transcellular biosynthesis. MPs or PMNs were preincubated with deuterium-labeled substrate (AA, EPA, and DHA, 100 ng each) before coincubation with macrophages for 1 hour at 37°C. Incubations were stopped with ice-cold MeOH and LM extracted. The levels of deuterium-labeled LM biosynthesized during the phagocytosis of apoptotic neutrophils were assessed by LC-MS/MS. (A) Representative MRM chromatograms of the identified LM. (B) Accompanying MS/MS spectra used for identification. (C) LM and precursor/pathway marker transition Q1-Q3 transitions along with mean ± SEM values for each of the mediators identified. The detection limit was ∼ 1 pg. *Below limits of detection. Cumulative values: (D) D-series resolvins, protectins, and maresins. (E) E-series resolvins and lipoxins. (F) Lipoxins. (G) Prostaglandins and thromboxanes. (C-G) Results are ± SEM; n = 5 distinct cell preparations. Jesmond Dalli, and Charles N. Serhan Blood 2012;120:e60-e72 ©2012 by American Society of Hematology

Distinct macrophage subtypes biosynthesize specific lipid mediator profiles. Distinct macrophage subtypes biosynthesize specific lipid mediator profiles. M1 and M2 macrophages were prepared from primary human monocytes after incubation with GM-CSF (20 ng/mL), IFN-γ (20 ng/mL), and LPS (100 ng/mL) to produce M1 or M-CSF (20 ng/mL) and IL-4 (20 ng/mL) to obtain M2. Incubations were stopped with ice-cold MeOH and taken for LC-MS/MS analysis (see “Sample extraction and lipid mediator metabololipidomics”). (A) Representative MRM chromatograms for the identified LM. Peak heights represent the relative levels of each mediator in the different macrophage subtypes. Cumulative levels for each lipid mediator category are represented as a function of color intensity, where color scales (eg, white to green for M1 macrophages and white to purple for M2 macrophages) are set from zero to 35 000 pg per 2.5 × 106 cells. (B) Accompanying MS/MS spectra used for identification. (C) Lipid mediator and precursor/pathway marker transition along with mean ± SEM values for each of the mediators identified. The detection limit was ∼ 1 pg. *Below limits. Cumulative values: (D) D-series resolvins, protectins, and maresins. (E) Lipoxins. (F) E-series resolvins and lipoxins. (G) Prostaglandins and thromboxanes. (H) EPA-derived prostaglandins and thromboxanes. (I) Leukotriene B4 (and 20-OH LTB4 metabolite). (J) Leukotriene B5. (D-J) Results are ± SEM; n = 8 distinct cell preparations. *P < .05 vs M1 group. **P < .01 vs M1 group. Jesmond Dalli, and Charles N. Serhan Blood 2012;120:e60-e72 ©2012 by American Society of Hematology

PMN and macrophage characteristic lipid mediator constitution. PMN and macrophage characteristic lipid mediator constitution. Lipid mediator levels were assessed for (A) ionophore-activated, zymosan-stimulated, apoptotic PMN and intact PMN (B) M1 and M2 macrophages. Results are representative of 4-8 separate cell preparations. For quantitative values, see Figures 3 and 5. Jesmond Dalli, and Charles N. Serhan Blood 2012;120:e60-e72 ©2012 by American Society of Hematology